
Sign up to save your podcasts
Or


Introducing Ozempic & Weight Loss Drugs: How They Work in Your Brain | The Oprah Podcast from The Oprah Podcast.
Follow the show: The Oprah Podcast
In this episode of The Oprah Podcast, Oprah sits down with Dr. Ania Jastreboff, an endocrinologist and associate professor at the Yale School of Medicine, to talk about the new GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound. Dr. Ania, who has been on the forefront of GLP-1 medication research for the past 20 years, will talk through why it is biologically difficult for some people to lose weight, maintain weight loss and why obesity is a disease. She explains how the new GLP-1 medications work, how they can facilitate weight loss, and if they are safe. Dr. Ania answers questions from people around the country who are taking the GLP-medications and have lost a significant amount of weight. We will also share an update from Amy Kane who told her story of losing 160 pounds on weight loss medications last year on Oprah’s ABC Special: Shame, Blame and the Weight Loss Revolution.
Also referenced in this episode: "The Let Them Theory: A Life-Changing Tool That Millions of People Can’t Stop Talking About" by Mel Robbins, published by Hay House LLC is available wherever books and audio books are sold.
SUPPORT THE SHOW
Subscribe: https://www.youtube.com/@Oprah
Find Oprah’s Interview with Mel Robbins Here.
Follow Amy on Instagram
Follow Amy on TikTok
Follow Emma on TikTok
Follow Emma on Instagram
Follow Oprah Winfrey on Social:
Learn more about your ad choices. Visit megaphone.fm/adchoices
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].
By Black Pearl Studios4.9
39393,939 ratings
Introducing Ozempic & Weight Loss Drugs: How They Work in Your Brain | The Oprah Podcast from The Oprah Podcast.
Follow the show: The Oprah Podcast
In this episode of The Oprah Podcast, Oprah sits down with Dr. Ania Jastreboff, an endocrinologist and associate professor at the Yale School of Medicine, to talk about the new GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound. Dr. Ania, who has been on the forefront of GLP-1 medication research for the past 20 years, will talk through why it is biologically difficult for some people to lose weight, maintain weight loss and why obesity is a disease. She explains how the new GLP-1 medications work, how they can facilitate weight loss, and if they are safe. Dr. Ania answers questions from people around the country who are taking the GLP-medications and have lost a significant amount of weight. We will also share an update from Amy Kane who told her story of losing 160 pounds on weight loss medications last year on Oprah’s ABC Special: Shame, Blame and the Weight Loss Revolution.
Also referenced in this episode: "The Let Them Theory: A Life-Changing Tool That Millions of People Can’t Stop Talking About" by Mel Robbins, published by Hay House LLC is available wherever books and audio books are sold.
SUPPORT THE SHOW
Subscribe: https://www.youtube.com/@Oprah
Find Oprah’s Interview with Mel Robbins Here.
Follow Amy on Instagram
Follow Amy on TikTok
Follow Emma on TikTok
Follow Emma on Instagram
Follow Oprah Winfrey on Social:
Learn more about your ad choices. Visit megaphone.fm/adchoices
DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to [email protected].

1,758 Listeners

7,639 Listeners

3,424 Listeners

12,176 Listeners

4,597 Listeners

8,254 Listeners

1,084 Listeners

4,662 Listeners

9,186 Listeners

2,554 Listeners

2,275 Listeners

3,051 Listeners

3,503 Listeners

687 Listeners

731 Listeners